Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06044896
Other study ID # UFPE 5.980.254
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 22, 2023
Est. completion date October 25, 2023

Study information

Verified date October 2023
Source University of Pernambuco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this experimental study, with crossover design, is to analyze the effects of body lateralization applied at 30 degrees compared to the supine position on the distribution of ventilation and regional lung aeration in healthy individuals. The main study questions to be answered are: - Question 1: What are the immediate effects of 30 degree body lateralization on the distribution of regional ventilation and lung aeration in healthy individuals? - Question 2: What is the effect of body lateralization on diaphragmatic mobility in the dependent or non-dependent hemithorax? Participants will be submitted to changes in positioning in bed, considering a randomized sequence of interventions, between supine position and body lateralization at 30 degrees, using the Multicare bed (Linet, Czech Republic). The interventions were repeated twice each with a 30-minute washout in each sequence. Participants will perform assessment of lung function and respiratory muscle strength with the instruments: - Manovacuometry - Spirometry - Ventilometry - Respiratory Diagnostic Assistant The supine and body lateralization positions will be compared, with the primary outcomes being lung aeration and ventilation distribution assessed using Electrical Impedance Tomography. The secondary outcome will be diaphragmatic mobility measured through lung ultrasound. Groups: - Supine position - Body lateralization Effects - Lung aeration - Distribution of ventilation - Diaphragmatic mobility


Description:

Body positioning is a therapy used in the hospital environment to improve oxygenation. Recent studies recommend lateralization therapy to improve lung function locally by positioning the chest region of interest upwards. However, there are still gaps in the description of the effects of body lateralization on lung aeration and ventilation between non-dependent and gravity-dependent regions and on diaphragmatic mobility. The objective of this study is to analyze the acute effects of lateralization on the aeration and distribution of lung ventilation, in comparison with the supine position, in healthy subjects. In addition, the effect of body positioning on diaphragm kinetics was evaluated. This is a crossover study, which will be carried out at the Hospital das Clínicas of the Federal University of Pernambuco (HC-UFPE). The sample will consist of 30 healthy volunteers, aged between 18 and 59 years, of both sexes. The change of body position will be performed using the Multicare bed (Linet, Praga,Czech Republic). Lung ventilation and aeration will be evaluated with an Enlight 1800 electrical impedance tomography (EIT) (Timpel Medical, São Paulo, Brazil). The EIT images will be segmented into four regions of interest (ROIs: anterior right, anterior left, posterior right and posterior left. Diaphragm mobility will be quantified by diaphragmatic ultrasound in the supine and lateral positions. The study was approved by the Research Ethics Committee of the Hospital das Clínicas of the Federal University of Pernambuco (EBSERH), in accordance with the norms of the National Health Council (Resolution 466/12) for research in human beings (opinion number 5,980.254).


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 25, 2023
Est. primary completion date October 25, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 59 Years
Eligibility Inclusion Criteria: - Healthy individuals - Volunteers aged between 18 and 59 years old (youth/adults) - Volunteers of both sexes Exclusion Criteria: - Individuals with contraindications for the use of manovacuometry, spirometry, ventilometry will be excluded - Volunteers who did not tolerate the positioning or interventions - Individuals with Grade III obesity (BMI > 40) - Participants with below-normal prediction values for manovacuometry and spirometry according to predefined formulas for men and women - History of flu syndrome in the last seven days.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Supine Positioning
The participant will be guided to the Multicare bed and will be positioned supine with the headboard not tilted. At this point, the participant will already have the EIT electrode belt and head, trunk and lower limb cushions around it, providing stability. After the participant has been correctly positioned, ventilatory monitoring will begin using the EIT. The environment must be fully controlled, that is, with adequate lighting, all collection members in silence, as well as the devices in the place, air-conditioned environment, without exposing the participant to heat or cold. Before starting the collection, the volunteer will be asked to try not to sleep or talk, making it clear that any discomfort can be reported at any time. To keep the volunteer awake, visual and sound stimuli can be performed. Furthermore, if you cough or sigh, the collection will restart. The intervention will last 5 minutes and will be repeated twice, with intervals between body lateralization.
Body Lateral Positioning
The participant will start from the bench press to the 30-degree lateral position. The cushions placed at the beginning of the collection will provide stability so that the inclination does not compromise the correct positioning of the participant, preventing them from sliding on the bed. Furthermore, it is also a safety measure for the participant. The environment will be controlled throughout the intervention and visual and sound effects will also be performed in lateral positioning. The volunteer will remain in this position for five minutes and shortly after will be placed in the supine position again. To start the protocol for the second and final time, the participant will have a washout time of thirty minutes.

Locations

Country Name City State
Brazil Hospital das Clínicas da UFPE Recife
Brazil Shirley Campos Recife Pernambuco

Sponsors (5)

Lead Sponsor Collaborator
University of Pernambuco Brazilian National Council for Scientific and Technological Development (CNPq), Coordination for the Improvement of Higher Education Personnel, Pernambuco Research Foundation (FACEPE), Universidade Federal de Pernambuco

Country where clinical trial is conducted

Brazil, 

References & Publications (3)

American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624. doi: 10.1164/rccm.166.4.518. No abstract available. — View Citation

Laveneziana P, Albuquerque A, Aliverti A, Babb T, Barreiro E, Dres M, Dube BP, Fauroux B, Gea J, Guenette JA, Hudson AL, Kabitz HJ, Laghi F, Langer D, Luo YM, Neder JA, O'Donnell D, Polkey MI, Rabinovich RA, Rossi A, Series F, Similowski T, Spengler CM, Vogiatzis I, Verges S. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J. 2019 Jun 13;53(6):1801214. doi: 10.1183/13993003.01214-2018. Print 2019 Jun. — View Citation

Testa A, Soldati G, Giannuzzi R, Berardi S, Portale G, Gentiloni Silveri N. Ultrasound M-mode assessment of diaphragmatic kinetics by anterior transverse scanning in healthy subjects. Ultrasound Med Biol. 2011 Jan;37(1):44-52. doi: 10.1016/j.ultrasmedbio.2010.10.004. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Respiratory pattern variables Respiratory pattern variables will be measured by the Respiratory Diagnostic Assistant.
The algorithm of the "Respiratory Diagnostic Assistant" device relates the variables respiratory rate, tidal volume, minute volume, inspiratory flow, expiratory flow, relationship between inspiratory and expiratory times.
Data are given in:
Respiratory rate in incursion per minute
Tidal volume (measured in liters)
Minute volume (measured in liters);
Inspiratory flow (measured in liters);
Expiratory flow (measured in liters);
Ti/Ttotal, (measured in seconds)
I:E, relationship between inspiratory and expiratory times
Volume vs time;
Flow vs time.
Not later than 12 months after primary completion date
Other Frequency of normal and altered breathing patterns The frequency of normal and altered breathing patterns will be measured by the Respiratory Diagnostic Assistant.
The "Respiratory Diagnosis Assistant" algorithm provides the classification of the diagnosis of breathing patterns as normal or altered, considering the input variables of flow, volume and time.
The normal breathing pattern described in the frequency of cases is when there is no change assessed by the algorithm.
The altered breathing pattern described in the frequency of cases are changes in the breathing pattern variables captured by the device's flow sensor during breathing at rest.
Data are given in:
• Absolut and relative frequencies
Not later than 12 months after primary completion date
Other Lung function measured by Spirometry Lung function tests are performed by the callibrated spirometer following American Thoracic Society guidelines (2019).
The analysis variables will be:
Forced vital capacity (FVC) - given in liters and percentage of predicted value
Forced expiratory volume in 1 second - (FEV1) - given in liters and percentage of predicted value
Relationship between FVC/FEV1 - given in measured value and percentage of predicted value
Furthermore, it allows you to draw up a functional diagnosis:
Normal
Obstructive ventilatory disorder (mild, moderate or severe)
Restrictive ventilatory disorder (mild, moderate or severe)
Mixed ventilatory disorder (with detection of obstructive and restrictive abnormality) Data are given in: Percentages
Not later than 12 months after primary completion date
Other Lung volumes at rest breathing Lung volumes at rest breathing will be measured by calibrated ventilometer (Ferraris Mark 8 Wright Respirometer®,. United Kingdom).
Tidal volume (Vt) will be obtained by the ratio between minute volume (MV) and the respiratory rate (RR) observed during one minute of breathing at rest (Vt = MV/RR)
Data are given in:
Minute volume (MV) measured in liters per minute;
Tidal volume (TV), measured in liters.
Not later than 12 months after primary completion date
Other Lung capacities Lung capacities will be measured by calibrated ventilometer (Ferraris Mark 8 Wright Respirometer®,. United Kingdom).
Inspiratory capacity (IC) - It's the maximum volume voluntarily inspired from the end of a spontaneous expiration (from the resting expiratory level).
Slow vital capacity (SVC) - measurement taken slowly, starting from a position of full inspiration for complete exhalation.
Data are given in:
Inspiratory capacity - measured in liters
Slow vital capacity - measured in liters
Not later than 12 months after primary completion date
Other Maximum inspiratory pressure (MIP) Measurement of the maximum static inspiratory pressure that a subject can generate at the mouth measuring inspiratory muscle strength measured by digital manometer (MVD300u, Homed, Brazil)
Maximum inspiratory pressure (measured in cmH2O)
Maximum predicted inspiratory pressure (predicted %) - MIP predicted =63,27-0,55 (age)+17,96 (sex)+0,58 (weight )
Data are given in:
CmH2O
percentage of predicted value
Not later than 12 months after primary completion date
Other Maximum expiratory pressure (MEP) Measurement of the maximum static expiratory pressure that a subject can generate at the mouth measuring expiratory muscle strength measured by digital manometer (MVD300u, Homed, Brazil)
Maximum expiratory pressure (cmH2O)
Maximum predicted expiratory pressure (predicted %)
MEP =-61,41+2,29 (age)-0,03 age2)+33,72 (sex)+1,40 (waist)
Data are given in:
CmH2O
percentage of predicted value
Not later than 12 months after primary completion date
Primary Change in end-expiratory lung impedance (Delta EELZ) Lung aeration will be assessed using Electrical Impedance Tomography (EIT). Regional EELZ will be calculated and analyzed concerning intervention times.
The change in aeration distribution or change in end-expiratory lung impedance (Delta EELZ) will be determined by comparing pre- and post-intervention EELZ for lung quadrants and dependent/non-dependent regions in each intervention.
End-expiratory lung impedance (EELZ) represents the sum of the end-expiratory impedance values of the pixels in a given region of interest. Regions of interest include: right anterior, left anterior, right posterior and left posterior, and functionally, dependent or non-dependent lung.
Continuous EIT monitoring will occur, and outcomes will be assessed before and after each intervention, each lasting five minutes.
Data are given in:
arbitrary units (a.u.)
mililiters
percentages
Not later than 12 months after primary completion date
Primary Change in distribution of lung ventilation (Delta Z) The distribution of lung ventilation will also be assessed using electrical impedance tomography.
The impedance variation (Delta Z) represents the sum of the impedance values of the pixels in a given region of interest. Regions of interest include: right anterior, left anterior, right posterior and left posterior, and functionally, dependent or non-dependent lung.
The change in distribution of lung ventilation will be obtained by the difference between the Delta Z before and after each intervention, comparing the measurements of the lung quadrants and in the dependent and non-dependent lung regions for each intervention.
Continuous EIT monitoring will occur, and outcomes will be assessed before and after each intervention, each lasting five minutes.
Data are given in:
arbitrary units (a.u.)
mililiters
percentages
Not later than 12 months after primary completion date
Secondary Difference in diaphragmatic mobility measured by ultrasound between the supine and body lateralization positions. Diaphragmatic mobility will be evaluated in the supine position and in the body lateralization position during the intervention using ultrasound, according to protocol from TESTA, A. et al 2011.
Measurements will be carried out with the patient breathing spontaneously in supine and body lateralization position at 30º.
Data are given in:
• Millimeters.
Not later than 12 months after primary completion date
See also
  Status Clinical Trial Phase
Completed NCT02101801 - Urine Drug Levels Related to Source of Water for Irrigation for Vegetable Crops Among Healthy Israeli Volunteers N/A
Recruiting NCT06101641 - Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals N/A
Completed NCT03065283 - Effects of Diaphragm-releasing Techniques on the Lumbar Spine and Diaphragmatic Function in Healthy Women N/A
Recruiting NCT01721811 - Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism N/A
Completed NCT01211717 - The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients N/A
Completed NCT01568541 - Fluoride Intake From Toothbrushig With Children's or Regular Toothpastes N/A
Completed NCT04941196 - Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition Phase 1
Completed NCT05541094 - Study of Vitamin D Fortification of Milk and Oil
Completed NCT05597657 - Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals N/A
Completed NCT03728868 - Tolerability and Risk of Adverse Events With a Probiotic Supplement N/A
Recruiting NCT04513782 - The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss
Completed NCT05637060 - Bioequivalence Study of Rosuvastatin Tablet N/A
Not yet recruiting NCT05110885 - Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices
Completed NCT01134978 - Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study Phase 1
Completed NCT06137534 - Upper Extremity Pattern Exercises and Respiratory Functions N/A
Completed NCT04873570 - Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects Phase 1
Enrolling by invitation NCT01872091 - Analysis of Neuromuscular, Circulatory and Biomechanical Responses After Cryotherapy N/A
Completed NCT01872117 - Assessment of Temperature by Infrared Thermography and Blood Conduction Velocity by Doppler After Applying Shortwave Diathermy and Microwave - Correlations With Cardiovascular and Hemodynamic Parameters N/A
Completed NCT02409836 - A Study to Assess the Ingestion of Dentifrice by Children N/A
Recruiting NCT05358561 - Postprandial Glucose, Insulin and Subjective Saturation Response in Healthy Individuals N/A